Analysts
Scores, price targets and rating changes published by the firms we track. Informational, not advice.
Price target forecast
The average analyst target through the past year, and where analysts see the price a year from now.
Nov 6, 20260 analyst targets · 90 days
- Share price
- $68.06
- Average 1Y price target
- $92.20+35.47%
- Agreement
- Fair
Analysts agreement range is spread 15% to 30% from the average
Share priceAverage analyst target (90-day window), shaded 10th–90th percentile12-month range from the lowest to the highest current target, dashed to the average
Rating scores
Each factor is scored 1 (weak) to 5 (strong).
- Overall4
- DCF4
- Return on equity5
- Return on assets5
- Debt / equity2
- P/E4
- P/B3
Average price target
Mean of the targets analysts published in each window.
| Window | Targets | Average |
|---|---|---|
| Last month | 4 | $99.00 |
| Last quarter | 6 | $97.50 |
| Last year | 19 | $76.32 |
| All time | 37 | $54.14 |
Recent rating changes
The latest 40 changes by research firm, newest first.
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 15, 2026 | Goldman Sachs | downgrade | Buy | Neutral |
| Sep 14, 2026 | Raymond James | maintain | Outperform | Outperform |
| Aug 11, 2026 | Mizuho | maintain | Outperform | Outperform |
| Aug 7, 2026 | TD Cowen | maintain | Buy | Buy |
| Jul 23, 2026 | Goldman Sachs | maintain | Buy | Buy |
| Jul 21, 2026 | TD Cowen | maintain | Buy | Buy |
| Jul 13, 2026 | Raymond James | maintain | Outperform | Outperform |
| Jul 9, 2026 | Mizuho | maintain | Outperform | Outperform |
| Jul 8, 2026 | UBS | maintain | Neutral | Neutral |
| May 27, 2026 | Mizuho | upgrade | Neutral | Outperform |
| Apr 10, 2026 | Goldman Sachs | upgrade | Neutral | Buy |
| Apr 9, 2026 | UBS | maintain | Neutral | Neutral |
| Apr 8, 2026 | Piper Sandler | maintain | Overweight | Overweight |
| Apr 8, 2026 | JP Morgan | maintain | Overweight | Overweight |
| Mar 25, 2026 | Raymond James | maintain | Outperform | Outperform |
| Mar 17, 2026 | Mizuho | maintain | Neutral | Neutral |
| Mar 12, 2026 | Goldman Sachs | maintain | Neutral | Neutral |
| Jan 12, 2026 | Piper Sandler | maintain | Overweight | Overweight |
| Jan 8, 2026 | Piper Sandler | maintain | Overweight | Overweight |
| Dec 12, 2025 | Mizuho | maintain | Neutral | Neutral |
| Nov 14, 2025 | Piper Sandler | maintain | Overweight | Overweight |
| Nov 11, 2025 | Mizuho | maintain | Neutral | Neutral |
| Nov 5, 2025 | UBS | maintain | Neutral | Neutral |
| Oct 22, 2025 | Goldman Sachs | maintain | Neutral | Neutral |
| Oct 17, 2025 | Raymond James | maintain | Outperform | Outperform |
| Sep 23, 2025 | UBS | maintain | Neutral | Neutral |
| Sep 15, 2025 | Mizuho | maintain | Neutral | Neutral |
| Sep 11, 2025 | Piper Sandler | maintain | Overweight | Overweight |
| Sep 9, 2025 | Raymond James | maintain | Outperform | Outperform |
| Jul 15, 2025 | Raymond James | maintain | Outperform | Outperform |
| Jul 11, 2025 | Mizuho | maintain | Neutral | Neutral |
| Jul 10, 2025 | Piper Sandler | maintain | Overweight | Overweight |
| Jun 30, 2025 | Raymond James | maintain | Outperform | Outperform |
| May 28, 2025 | Goldman Sachs | downgrade | Buy | Neutral |
| May 13, 2025 | Mizuho | maintain | Neutral | Neutral |
| May 8, 2025 | Piper Sandler | maintain | Overweight | Overweight |
| Apr 16, 2025 | UBS | maintain | Neutral | Neutral |
| Apr 11, 2025 | Mizuho | maintain | Neutral | Neutral |
| Mar 27, 2025 | Goldman Sachs | upgrade | Neutral | Buy |
| Mar 7, 2025 | Piper Sandler | maintain | Overweight | Overweight |